A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors

By Michaux C.   Dogne J.-M.   Rolin S.   Masereel B.   Wouters J.   Durant F.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite

G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3162-3214

Bentham Science Publishers

Access to resources Recommend Favorite

Thromboxane-prostanoid receptor expression and antagonism in dextran-sodium sulfate-induced colitis

By Carter Patsy   McElhatten Robert   Zhang Songlin   Wright William   Harris Norman  

Inflammation Research, Vol. 60, Iss. 1, 2011-01 ,pp. : 87-92

Springer Publishing Company

Access to resources Recommend Favorite

Glutamate Receptor Agonists: Stereochemical Aspects

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 7, 2011-01 ,pp. : 887-906

Bentham Science Publishers

Access to resources Recommend Favorite